There are some reviews on immune organoids that I posted below. This is the first human one though able to recapitulate these features at a commercial scale. W

There are some reviews on immune organoids that I posted below. This is the first human one though able to recapitulate these features at a commercial scale. We haven't gotten any feedback from med chemists yet! The cost is comparable to other in vitro systems and is cheaper than using animals. *The data collection can be very granular. You can use single cell techniques like flow and RNA-seq to generate high resolution data. You can also use high resolution imaging techniques like CODEX. Moving into high throughput and building predictive models is exactly where we want to go. Currently, we can generate 7500 organoids from a single donor and screen them in the thousands. We're working on building a ML pipeline along with automation so that we can screen in the hundreds of thousands if not more. Key to this though is that we have designed a platform that is amenable to this kind of automation and scale.